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Introduction
The coexistence of mutations in more than one gene,
linked to Autoinflammatory Diesases, can confuse and
make difficult the diagnosis and management of these
patients, especially in childhood, when the clinical history
is still brief.
Objectives
However therapeutic decisions are often necessary and
can significantly modify clinical outcome and long term
prognosis.
Methods
We report the clinical case of a 4 years old child who
presented arthralgia since the age of 2,5 years. An ortho-
paedic diagnosed them as “growing pain”. Some months
later he presented fever, neutrophilic leucocytosis, signifi-
cant elevation of CRP and ESR associated to legs pain; he
was treated with antibiotics and NSAID with a poor
response.
In the last year these episodes were monthly recurrent,
associated with abdominal pain, oral aphtae, exanthema,
conjunctivitis. The attacks are 3-4 sometimes 7 days long,
have a monthly recurrence and do not show a seasonal
prevalence. He showed a weight loss (weight: -2SDS;
height: -1SDS); in the free intervals he was in wellbeing.
Results
During an attack he showed: increased CRP, ESR, alfa2,
IgA; neutrophilic leucocytosis, serum amyloid-A (SAA):
65 mg/L (n.v. <6). In the free- attack period the SAA was
in the normal range.
The genetic study of FMF, TRAPS, MVK evidenced the
following mutations: heterozygous mutation of MEFV
gene: K695R; heterozygous mutation of TNFRS1A
gene: P46L. He started colchicine with only a moderate
improvement of clinical and laboratory data. He
prolonghed this treatment for three months but for the
persistence of symptoms and elevated SAA levels a treat-
ment with biologic drugs anti-IL1 was programmed.
The genetic study was extended to the entire family: the
father, a patient with Multiple Sclerosis (MS) diagnosed at
29 years, showed the same mutation of the son. The
mother and the brother were negative. The father revealed
a personal history of recurrence of pharyngitis, fever,
arthralgia, legs myalgia, headhache, partially related also
to MS.
The association between MEFV gene mutations and MS,
the TNFRSF1A gene R92Q mutation and MS, in patients
who refer symptoms related to TRAPS.
However a link between NLRP3 gene mutations and MS
is also reported in patients in whom MR documented a
partial reduction of lesions after anti-IL1 treatment. In
these cases the anti-IL1 drugs remitted recurrent episodes
related to CAPS.
The NLRP3 gene study was performed and revealed the
mutation Q703K both in the father and in the son. The
treatment with Canakinumab was started and a resolution
of recurrent attacks in the son and a reduction of legs pain
in the father. The treatment for MS is however continued
in the father.
Conclusion
The follow up is still ongoing; the relieve of the NLRP3
mutation permitted the treatment with anti-IL1 otherwise
difficult.
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